← Open Payments lookup

REBECCA BEITLER-WALSH: Open Payments

NPI 1427116920 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$434 in 23 payments from 8 companies in 2025. Trend: 2023 $52 · 2024 $427 · 2025 $434

Food & beverage: $434
CompanyPaymentsAmount
GlaxoSmithKline, LLC.5$135
GENZYME CORPORATION3$85
AstraZeneca Pharmaceuticals LP5$84
Electromed, Inc.5$33
Insmed, Inc.2$29
Bayer Healthcare Pharmaceuticals Inc.1$28
Merck Sharp & Dohme LLC1$22
Boehringer Ingelheim Pharmaceuticals, Inc.1$16

Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, FASENRA, SMARTVEST, Arikayce, Adempas, WINREVAIR.

Industry payments across CO — which companies pay providers there.